Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease. [electronic resource]
Producer: 20200218Description: 723-738 p. digitalISSN:- 2328-9503
- Acetamides -- pharmacology
- Alzheimer Disease -- drug therapy
- Amyloid beta-Peptides -- metabolism
- Animals
- Brain -- drug effects
- Drug Repositioning -- methods
- Humans
- Intermediate-Conductance Calcium-Activated Potassium Channels -- antagonists & inhibitors
- Mice, Transgenic
- Microglia -- drug effects
- Trityl Compounds -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.